chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse concerning a patient who was vaccinated po with a dose of ROTATEQ (date and number of dose unspecified). The nurse reported that the patient developed rotavirus, confirmed by the office lab technician. It was reported that the patient sought medical attention, unspecified. The outcome was not reported. This is one of several reports from the same source. Additional information has been requested.  09/02/2008 This is in follow-up to report(s) previously submitted on 7/15/2008. Information has been received from a nurse concerning a 15 month old male with no medical history who was vaccinated PO on 08-MAY-2007, 11-JUL-2007 and 11-SEP-2007 with the first, second and third dose respectively of ROTATEQ (first and second dose lot # 656390/0236U and third dose lot # 654665/0694F). The patient did not have any illness at the time of vaccination. The nurse reported that the patient developed rotavirus, confirmed by the office lab technician. It was reported that the patient sought medical attention, unspecified. The outcome was not reported. Folllow-up information was received from a nurse. On 05-JUN-2008 the patient developed diarrhea that lasted one week. A stool test was done which was positive for Rotozyme, hematest negative and no fecal white blood cells seen. It was reported that the patient was seen for a doctor visit. The patient was reported as recovered on approximately 12-JUN-2008. This is one of several reports from the same source. Additional information has been requested.
Patient contracted Varicella. Patient had body rash diagnosed as Varicella 3/1/10 after receiving both doses of Varicella vaccination.
Pt developed tension-migraine headache since 3/99, but none within 30 days of vaccine. Pt developed moderate local reactions, self-limiting, after Anthrax vaccines, 1,2,3, and 4. Diagnosed with allergic rhinitis.
red band on skin surrounding injection site. not itchy, not excessively sore, not hot, no swelling, no discomfort
Bad asthma; when she has an attack, she can't breathe; This is a spontaneous report received from a contactable consumer from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Does not drink" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ASTHMA (non-serious), outcome "unknown", described as "Bad asthma; when she has an attack, she can't breathe". Therapeutic measures were taken as a result of asthma.  Additional Information: The patient received all her COVID-19 Vaccines through Pfizer and never had a reaction to them and has never had COVID-19 and is perfectly healthy, except that she has bad asthma. When she has an attack, she can't breathe. The patient has an inhaler.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300041333 Same patient and product; different event and dose;
PATIENT CALL PHARMACY AND SAID SOAR AND REDNESS AROUND THE INJECTION SITE.  NO FEVER OR OTHER REACTION. TOLD PATIENT TO USE ICE PACK FOR WHILE , NEXT DAY FOLLOW UP WITH PATIENT AND SAID PAIN REDUCED AND BUT STILL REDDISH AROUND THE INJECTION SITE. OFFER TO CONTACT PCP BUT DENIED SAID WILL WAIT AND HAVE APPOINTMENT WITH DR AND WILL ASK HIM TO SEE.
Patient stated the next morning she awoke with a temperature of 102 degrees that lasted 48 hours.  She had "muscle aches,the muscle in the right deltoid swelled to baseball size, the area was warm to touch."  She states she was sick for 3 days.  She talked with her doctor via the telephone but no office visit was required.
Vial was initially stored in the refrigerator on 10-Jun-2022 and adminsitered on 12-Jul-2022; Dose administered after 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 10-Jun-2022 and adminsitered on 12-Jul-2022) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 10-Jun-2022 and adminsitered on 12-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 10-Jun-2022 and adminsitered on 12-Jul-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient weight was reported as 175.  Concomitant medication was not provided.  15 patients were vaccinated after the 30 day beyond use date. Number of doses per vials were 15 doses.  The vial was initially stored in the refrigerator on 10-Jun-2022. The vial did not undergo any temperature excursions.   Treatment information was not provided.
After PPD - Pt felt lightheaded and had syncope episode - no LOC - Vasovagal V/S stable. See f/u - 4/5/10.
Client received the 1st dose of Pfizer COVID vaccine (lot # EW0182 and expiration date 5/15/21)  at 2:47pm.  Client walked over to EMT to report that she was having pain on the opposite arm where vaccine was given and that she would like her blood pressure taken (vaccine given in left arm, pain in right arm). PHN  finds patient alert and oriented x 4 sitting in a chair.  Client reports she had been waiting 20 minutes in observation. Client reports a history of hypertension. Per client, she was not sure about taking her nifedipine, so she did not take her medication at the regular time.  Client states she takes Losartan and took it this morning.  Client denies any chest pain, headache, blurred vision, dizziness, or shortness of breath.  At 3:14pm vitals: blood pressure:173/103, pulse:60, and oxygen: 98%.  At 3:20pm vitals: blood pressure:161/106, pulse:60, and oxygen:99%. Client reports no symptoms.  PHN  came to speak to client and patient reports she has her medication with her and took it out of her purse. Client thought she should not take medication because she was getting the vaccine. Client also stated when she does not take her medication 160-180 systolic is her regular blood pressure at home.  PHN  let client know that she should take medication as prescribed. Client took 2nd dose of hypertension medication (Nifedipine) at 3:24pm. PHN recommended client to stay for further observation as blood pressure is high.  At 3:25pm vitals: blood pressure:155/94, pulse:63, and oxygen:99%.  Client reports no more arm pain on right arm and that "she was a little nervous about the vaccine and that her blood pressure goes up easily.".  At 3:30pm  vitals: blood pressure:160/99,  pulse:66, and oxygen:98%. Client reports she is feeling better and was provided with ER precautions and to notify her provider about her blood pressure readings. Also recommended client eating and taking medication prior to dose #2. Client reports no shortness of breath, no headache, no arm pain, no chest pain, no blurred vision. At 3:38pm, vitals are: blood pressure: 152/99, oxygen:99, and pulse:60. Client reports no symptoms.  At 3:44pm vitals: blood pressure: 148/99, pulse: 60 and oxygen: 98%.  Client walked out with a steady gait at 3:46PM.
patient received 1st dose of Heplisav B vaccine for pre-employment  physical when she was 10-11 weeks pregnant
had pneumonia; was sick; This case was reported by a consumer via interactive digital media and described the occurrence of pneumonia in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pneumonia (serious criteria GSK medically significant) and sickness. On an unknown date, the outcome of the pneumonia and sickness were unknown.   It was unknown if the reporter considered the pneumonia and sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that last time took the flu vaccine, the patient was sick all winter, had pneumonia and everything. The patient would think to take chances.
pain at the injection site; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had injection site pain. The reporter asked was it common to had pain at the injection site for 4 days.
I got the injection about 9:00 AM Wednesday morning. 4 hours after the injection my shoulder and upper arm started getting sore.  An hour later I could not move my arm and if I tried to lift it, the pain was 10 on the 1 to 10 scale.  I left work at 2:00 and went home. The next morning I called the doctor's office and they told me to go to Urgent Care. I went, and left there with my arm in a sling and perscriptions for muscle relaxers, anti inflamatory and paid patches. The first 4 nights I could hardly sleep. It was hard to find a position that didn't hurt, and once I did fall asleep, I would roll over and the pain would wake me up.  On Sunday the pain started to subside, and each day after was a little better.  Today is Thursday, 8 days following the injection.  I still have pain when I move my arm in certain directions, but the pain now is only 1 - 2 on the 1 - 10 scale.   only occasionally wake up during the night after rolling over on that arm. I would think by now the pain would be gone.  The information sheet I was given on the vacine said extreme pain and restricted movement are possible but "very rare".  I certainly had both, and now, 8 days later, some effects are still with me.
Menstrual cycle changes.  Menstrual cycle started 7 days early and unusually heavy and longer. No treatment.
On 3/28/07 mother stated infant screamed and had red swollen legs after 2 mo shots on 1-24-07
severe neuropathy; pain affecting entire low body; feeling pain in the spine; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (severe neuropathy) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced SPINAL PAIN (feeling pain in the spine). On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (severe neuropathy) (seriousness criterion medically significant) and PAIN (pain affecting entire low body). At the time of the report, NEUROPATHY PERIPHERAL (severe neuropathy) outcome was unknown and SPINAL PAIN (feeling pain in the spine) and PAIN (pain affecting entire low body) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: results not reported (Inconclusive) Results not reported. On an unknown date, Magnetic resonance imaging: results not reported (Inconclusive) Results not reported. On an unknown date, Positron emission tomogram: results not reported (Inconclusive) Results not reported. On an unknown date, X-ray: results not reported (Inconclusive) Results not reported.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on concomitant medication but she did not give any specifications about them.  No treatment information was provided. Patient stated that went to doctor´s and surgeon´s appointments. Company Comment This case concerns a 53-year-old, female patient with no relevant medical history reported, who experienced the unexpected event of neuropathy peripheral. The events occurred the same day after the first dose of mRNA-1273. The rechallenge was unknown since no information regarding the second dose was disclosed. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2021-416137 (Patient Link).; Sender's Comments: This case concerns a 53-year-old, female patient with no medical history reported, who experienced the unexpected event of spinal pain on the same day after the first dose of mRNA-1273 vaccine. She also experienced the unexpected serious event of neuropathy peripheral (reported as severe neuropathy) and pain at an unknown date. The event spinal pain was reported after both doses of the vaccine, however, since the outcome had not resolved, the rechallenge is not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.  Case was assessed as serious due to important medical event and medical judgement.
itchy( at site), hard, hot and  red golfball sized lump at injection site followed by area of redness approximately 4"x5"  around the injection site lasting 4 days.
Mild soreness in left shoulder for 24 hours after receiving the 1st dose COVID vaccine. Light headedness and feelings of faint 2 weeks after 1st dose of COVID vaccine. Mild case of Shingles on left leg shin and behind knee 2 weeks after 1st done of COVID vaccine. Treatment for Shingles: Triamcinolone Acetonide Cream, Valacyclovir 1GM Tablet to take by mouth 3 times daily.
Mallet finger 4th finger , R hand . Swollen finger joints.  Burning feet, joint pain.
My back felt slightly itchy. When I touched the area, which was the center of my back between my shoulder blades, there was a patch of small hives approximately 4 inches in diameter. The hives grew larger over the next hour or two until it was almost one large raised mass of large hives, still around 4 inches in diameter. The hives were not particularly itchy or bothersome, but they remained in the exact location for 5 days, after which they began slowly receding. They were completely gone by one week later, but during day 5 and 6 the hives had become very small pinpoint bumps that felt almost like there were small scabs on them. The patch of hives never oozed, itched significantly, or had broken skin.
SORE THROAT; LEFT SIDE OF BODY WAS SORE AND ACHY (UNDER THE ARM, BREAST AND BACK); MUSCLE SPASM ON THE BACK OF RIBCAGE AND KNEE; FEVER; NAUSEA; This spontaneous report received from a parent concerned an 18 year old female. The patient's weight was 120 pounds, and height was 62 inches. The patient's past medical history included anterior cruciate ligament surgery of the knee, and other pre-existing medical conditions included no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A and expiry: Unknown) dose was not reported, administered on 26-JUL-2021 15:30 for prophylactic vaccination. No concomitant medications were reported. On 27-JUL-2021, the subject experienced sore throat. On 27-JUL-2021, the subject experienced left side of body was sore and achy (under the arm, breast and back). On 27-JUL-2021, the subject experienced muscle spasm on the back of ribcage and knee. On 27-JUL-2021, the subject experienced fever. On 27-JUL-2021, the subject experienced nausea. Laboratory data included: Body temperature (NR: not provided) 100.5 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and the outcome of sore throat, nausea, left side of body was sore and achy (under the arm, breast and back) and muscle spasm on the back of ribcage and knee was not reported. This report was non-serious.
PPD & Td vials sitting next to each other;picked up Td by mistake, w/drew 0.1cc as if placing PPD test;pt informed when error realized;hlth dept also informed;
I received a flu shot Thursday (2/3/05) afternoon, that evening I got a fever 102 my body ached all over. I took Tylenol 2 every 4 to 6 hrs. Temperature was back to normal Saturday morning.
1/27/2021 experience sore throat, chills, fever 101.8 F, and body aches. 1/28/2021 still experiencing symptoms. Was sent to be test for Covid. Results were negative. 1/29/2021 Developed a dry nagging non-productive cough.  I would have coughing fits that would last for 30-45 minutes, which would be followed by clear sinus drainage. I began taking Benadryl 50 mg q 4 hrs.  with very little relief. 2/2/2021 I was seen at urgent care for this cough. CXR was negative. No signs of infection.  I started prednisone 40 mg  x 5 days, and Tessalon Perles 200 mg 3 times a day.  I was still experiencing the dry cough and by 2/5/2021 had to leave work because the coughing was not letting up.  I was now also experiencing my ears and throat itching.  I again started taking Benadryl and sudafed q 4 hours.  2/7/2021 I tried to come off the benadryl and experienced ears itching, my throat itching, my lips were going numb and my tongue felt like it was swelling.  2/8/2021 I was seen by my primary care physician. There was no signs of infection. Ears were clear, chest was clear.  He told me he felt I was having a reaction to the COVID vaccine, and experiencing a reactory cough as well.  He gave me a Steroid injection in the office, prescribed me a steroid inhaler twice a day, and  Bromfed cough syrup every 6 hrs  prn. 2/9/2021 cough has subsided as well as the itching.
Information has been received on 11-SEP-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 20-JUL-2015, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 27-JUN-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. The patient was prescribed VALTREX for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
I started experiencing hearing loss after my second booster vaccine. I made an appointment with the ENT specialist, he gave me a steroid injection in my inner ear. I have not recovered and I am being monitored for any changes.
CHILD UNDER THE AGE OF 12 YR RECEIVED VACCINE FOR >12 YR OLD
CHILLS; FEVER; MUSCLE ACHES; FEELING TIRED; FEELING WEAK; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's past medical history included lung transplant, and liver transplant, and concurrent conditions included hepatitis c.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced muscle aches. On 08-APR-2021, the subject experienced feeling tired. On 08-APR-2021, the subject experienced feeling weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 09-APR-2021, and had not recovered from muscle aches, feeling tired, and feeling weak. This report was non-serious.
HR 80, 98 SPO2 on RA, 170/98 , 2 160/92, 99 % RA HR 98, 99 % HR 88, 160/90 Pt states she feels dizzy, denies pain at the site. Says she does have DMII and HTN. Ambulated to restroom with RN, given bottle of water, states she has not eaten all day, states she feels anxious and vision is blurry. Pt denies headache, weakness, pain, nausea. Patient verbalized understanding to f/u with 911 or ED with any further problems. Pt also signed hardcopy.
Case number PHEH2015US002910, is an initial spontaneous report received from a Healthcare Professional on 06 Feb 2015. This report refers to a 42 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1412801) intramuscularly at a dose of 0.5 ml on 12 Jan 2015. It was reported that before administration, the FLUVIRIN was stored at 34 degree Fahrenheit for 15 hours. No adverse event was reported following this maladministration.
Vaccine given to patient was expired, Vaccine expiration date 03/27/2022 Est date of delivery is 09/03/2022
Information has been received from a health professional concerning a 29 year old female who on 17-NOV-2006 was vaccinated subcutaneously on the right thigh with the first dose of Gardasil.  On 17-NOV-2006 the patient experienced drug administered via inappropriate route.  The reporter felt that drug administered via inappropriate route was not related to therapy with Gardasil.  No problems were reported and no further information was available.  Follow-up information received 23-JAN-2008: Per the reporter, on 17-NOV-2006 the patient experienced a painful welt which lasted a couple of hours.  Subsequently, the patient recovered from the welt.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/14/2008. Information has been received from a health professional concerning a 29 year old female who on 17-NOV-2006 was vaccinated subcutaneously on the right thigh with the first dose of GARDASIL. On 17-NOV-2006 the patient experienced drug administered via inappropriate route. The reporter felt that drug administered via inappropriate route was not related to therapy with GARDASIL. No problems were reported and no further information was available. Follow-up information received 23-JAN-2008: Per the reporter, on 17-NOV-2006 the patient experienced a painful welt which lasted a couple of hours. Subsequently the patient recovered from the welt. Additional information has been requested.
Day 1 - Large red area on left arm near shoulder, approx 4"x4" itchy, tender Day 2 - Area increased in size to 4"x 6", swelling more visible, hot Day 3 - Area increased to 5"x 7" Looked at by doctor, began antibiotics. Some spots on right arm Day 4 - Area increased to 5" x 8", larger patch of hives appeared on lower arm and on upper and lower right arm